DOI QR코드

DOI QR Code

ISO14971:2019 Detailed Analysis and Periodic Safety Update Report Establishment Method for the Single Use Medical Device - Focusing on Medical Device Regulation 2017/745 requirements

일회용 의료기기에 적용을 위한 ISO 14971:2019 분석과 Periodic Safety Update Report 작성 방법 - Medical Device Regulation 2017/745 요구사항 중심으로

  • Sang Min, Park (Department of Medical Device Management and Research, SAIHST, Sungkyunkwan University) ;
  • Gyu Ha, Ryu (Department of Medical Device Management and Research, SAIHST, Sungkyunkwan University, Research Institute for Future Medicine, Samsung Medical Center)
  • 박상민 (성균관대학교 삼성융합의과학원 의료기기산업학과) ;
  • 류규하 (성균관대학교 삼성융합의과학원 의료기기산업학과, 삼성서울병원 미래의학연구원)
  • Received : 2022.10.15
  • Accepted : 2023.01.10
  • Published : 2023.02.28

Abstract

With the announcement of MEDICAL DEVICE REGULATION 2017/745 (MDR) on April 5 2017, medical device manufacturers shall apply ISO 14971:2019 (3rd) revised in December 2019. However, there is not much related information and guidance available to medical device manufacturers, especially single use medical device. Risk management process basically follow 5 steps which are Risk Analysis, Risk Evaluation, Risk Control, Evaluation of overall residual risk and post-production activities. The purpose of this study is to provide a guidance of from risk analysis with Failure Mode and Effects Analysis (FMEA) table to overall residual risk evaluation for the single use medical device and to reflect it in a Periodic Safety Update Reports (PSUR) to satisfy with MDR requirements with single use medical device which are widely used and manufactured FDA class 2 or CE class IIb as examples. For this study, single use medical device manufacturer can adopt ISO 14971:2019 in accordance with MDR requirements and it can be extended to the PSUR. But there are still limitations to adopt to the all-single use medical device especially high class, private device and implantable device. So, Competent Authority (CA) shall publish more guidance for the single use medical device.

Keywords

References

  1. COUNCIL DIRECTIVE 93/42/EEC of 14 June 1993 concerning medical devices. 1993;1-43.
  2. MFDS. Medical device manufacturing/import and quality Management standards. 2005.
  3. REGULATION (EU) 2017/745 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. 2017;1-175.
  4. MedTech Europe Survey Report Analysing the availability of Medical Devices in 2022 in connection to the Medical Device Regulation (MDR) implementation. 2022;3.
  5. MFDS. A year of 2021 Medical Device production and import/export performance statistical data. 2022;6-7.
  6. KHIDI. A year of 2020 Medical Device Industry Analysis Report; on March 2021;59:62.
  7. MFDS Risk management plan & report guidance, 2008.
  8. MOLEG. Medical Device Act Enforcement Rules; on Dec 19 2022. Attached form 1 of Article 2 related.
  9. MDCG 2021-24, Guidance on classification of medical devices; 2021;5.
  10. ISO 14971:2019 Medical devices, Application of risk management to medical devices, 2019;1-46.
  11. ISO/TR 24971:2020 Medical devices, Guidance on the application of ISO 14971. 2019;22-49.
  12. https://www.accessdata.fda.gov/scripts/cdrh/devicesatfda/index.cfm Accessed on 10 Jan 2023.
  13. Karolina N, Ewa J, Marzena G, Piotr R, Wioletta RW. Methylparaben-induced regulation of estrogenic signaling in human neutrophils. Mole. Cell. End. 2021;538;111470.
  14. MDCG 2022-21, Guidance on periodic safety update report (PSUR) according to regulation (EU) 2017/745 (MDR). 2022;21.